You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vinca

Showing 1 - 25 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vinca Alkaloid Adverse Reaction Trial (Loratadine, Diosmin/ Hesperidin)

Not yet recruiting
  • Vinca Alkaloid Adverse Reaction
  • (no location specified)
Feb 14, 2022

Standard Anti-microtubule Drugs as Assessed by Early Tumor

Recruiting
  • Breast Cancer
  • Breast Neoplasms
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 10, 2021

Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Metastatic Breast Cancer
  • Angers, France
  • +24 more
Mar 8, 2022

Chemo-induced Peripheral Neuropathy, Pediatric Cancer Trial in Basel (Playful sensorimotor training)

Recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • Pediatric Cancer
  • Playful sensorimotor training
  • Basel, Switzerland
  • +1 more
Nov 3, 2022

Neuropathy;Peripheral Trial in Houston (Abbott® DRG / Abbott®/Medtronic® SCS, Control Group)

Recruiting
  • Neuropathy;Peripheral
  • Abbott® DRG / Abbott®/Medtronic® SCS
  • Control Group
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Not yet recruiting
  • Thrombopoietin Receptor Agonist
    • (no location specified)
    May 4, 2023

    CIPN and it's Impact on Quality of Life in Patients Receiving

    Not yet recruiting
    • Chemotherapy-induced Peripheral Neuropathy
      • (no location specified)
      Apr 24, 2023

      Chemo-induced Peripheral Neuropathy Trial in Assiut (transcranial dirrect current brain stimuation)

      Recruiting
      • Chemotherapy-induced Peripheral Neuropathy
      • transcranial dirrect current brain stimuation
      • Assiut, Egypt
        South Egypt Cancer Institute
      Apr 3, 2021

      Mesothelioma Trial in Cardiff (Vinorelbine, Active Symptom Control)

      Completed
      • Mesothelioma
      • Cardiff, United Kingdom
        Wales Cancer Trials Unit
      Oct 4, 2021

      DLBCL Trial in Suzhou (Orelabrutinib, Rituximab, CHOP-like Regimen)

      Recruiting
      • Diffuse Large B-Cell Lymphoma
      • Suzhou, Jiangsu, China
        the First Affiliated Hospital of Soochow University
      Aug 10, 2022

      Chemo-induced Peripheral Neuropathy Trial in Minneapolis (Mobile Ecological Momentary Assessment)

      Recruiting
      • Chemotherapy-induced Peripheral Neuropathy
      • Mobile Ecological Momentary Assessment
      • Minneapolis, Minnesota
        Abbott Northwestern Hospital
      Apr 8, 2022

      Breast Cancer, Metastases Trial in Worldwide (vinflunine, Alkylating agent of physician choice registered in cancer)

      Completed
      Has Results
      • Breast Cancer
      • Metastases
      • vinflunine
      • Alkylating agent of physician choice registered in cancer
      • Buenos aires, Argentina
      • +79 more
      Aug 9, 2019

      Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)

      Active, not recruiting
      • Breast Cancer Metastatic
      • Los Angeles, California
      • +24 more
      Aug 10, 2022

      Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

      Not yet recruiting
      • Rhabdomyosarcoma
      • Palo Alto, California
      • +2 more
      Aug 27, 2023

      Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in United Kingdom (Epcoritamab, Lenalidomide, Rituximab)

      Not yet recruiting
      • Relapsed Follicular Lymphoma
      • Refractory Follicular Lymphoma
      • Aberdeen, United Kingdom
      • +24 more
      Apr 28, 2023

      Diagnostic of Chemotherapy Induced Neuropathy in Children

      Recruiting
      • Chemotherapy-induced Peripheral Neuropathy
      • electrochemical skin conductance measurement
      • Paris, France
        Necker- enfants maladies hospital
      Dec 6, 2021

      Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago

      Not yet recruiting
      • Breast Carcinoma
      • +2 more
      • Biospecimen Collection
      • +6 more
      • Chicago, Illinois
        Northwestern University
      Nov 14, 2023

      Rhabdomyosarcoma Trial in Sutton, Manchester (Irinotecan, Actinomycin D, Doxorubicin)

      Recruiting
      • Rhabdomyosarcoma
      • Camperdown, Australia
      • +89 more
      Jan 3, 2023

      Peripheral Nervous System Problem Trial in Salzburg (high tone external muscle stimulation, transcutaneous electrical nerve

      Completed
      • Peripheral Nervous System Problem
      • high tone external muscle stimulation
      • transcutaneous electrical nerve stimulation (TENS) therapy
      • Salzburg, Austria
        Paracelsus Medical University Salzburger Landeskliniken
      Sep 27, 2022

      NSCLC Trial in Australia, China, United States (Docetaxel + Plinabulin (DP), Docetaxel (D))

      Completed
      • Non-Small Cell Lung Cancer
      • Docetaxel + Plinabulin (DP)
      • Docetaxel (D)
      • Chandler, Arizona
      • +56 more
      Sep 9, 2022

      Chemo Induced Peripheral Neuropathy (CIPN) Trial (Stibium metallicum praeparatum 6x, Placebo)

      Not yet recruiting
      • Chemotherapy Induced Peripheral Neuropathy (CIPN)
      • Stibium metallicum praeparatum 6x
      • Placebo
      • (no location specified)
      Jan 21, 2022

      Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

      Active, not recruiting
      • Breast Cancer
      • +10 more
      • Los Angeles, California
      • +7 more
      Jun 21, 2022

      International CIPN Assessment and Validation Study

      Recruiting
      • Chemotherapy-induced Peripheral Neuropathy
      • Quality of Life
      • outcome measures for CIPN testing
      • Birmingham, Alabama
      • +29 more
      Apr 27, 2022

      Non Small Cell Lung Cancer Trial (EC145, EC145 + Docetaxel, Docetaxel)

      Completed
      • Non Small Cell Lung Cancer
      • (no location specified)
      Mar 30, 2021

      Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma Trial in United

      Recruiting
      • Embryonal Rhabdomyosarcoma
      • +2 more
      • Birmingham, Alabama
      • +47 more
      Aug 17, 2022